ECSP993095A - 1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS) - Google Patents
1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS)Info
- Publication number
- ECSP993095A ECSP993095A ECSP993095A ECSP993095A EC SP993095 A ECSP993095 A EC SP993095A EC SP993095 A ECSP993095 A EC SP993095A EC SP993095 A ECSP993095 A EC SP993095A
- Authority
- EC
- Ecuador
- Prior art keywords
- aryl
- respiratory
- disease
- naftiridin
- onas
- Prior art date
Links
Abstract
Un compuesto de fórmula (gráfico), o la sal farmacéuticamente aceptable del mismo, en la que R1, R2 y R3 son como se han definido anteriormente, útil en el tratamiento de trastornos respiratorios, alérgicos, reumatoides, de regulación del peso corporal, inflamatorios y del sistema nerviosos central, tales como asma, enfermedad pulmonar obstructiva crónica, síndrome de enfermedades respiratorias en adultos, choque tóxico, fibrosis, hipersensibilidad pulmonar, rinitis alérgica, dermatitis atópica, psoriasis, control de peso, artritis reumatoide caquexia, enfermedad de Crohn, colitis ulcerosa, afecciones artriticas y otras enfermedades inflamatorias, depresión, demencia multiinfarto y SIDA.A compound of formula (graph), or the pharmaceutically acceptable salt thereof, in which R1, R2, and R3 are as defined above, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulating, inflammatory disorders and of the central nervous system, such as asthma, chronic obstructive pulmonary disease, respiratory illness syndrome in adults, toxic shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis cachexia, Crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993095 ECSP993095A (en) | 1999-08-11 | 1999-08-11 | 1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993095 ECSP993095A (en) | 1999-08-11 | 1999-08-11 | 1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993095A true ECSP993095A (en) | 1999-10-06 |
Family
ID=42044082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993095 ECSP993095A (en) | 1999-08-11 | 1999-08-11 | 1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993095A (en) |
-
1999
- 1999-08-11 EC ECSP993095 patent/ECSP993095A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9810733A (en) | Nicotinamide derivatives | |
| SV1999000120A (en) | 1-ARIL-3-ARILMETIL-1,8-NAFTIRIDIN-4 (1H) -ONAS REF. PC10020 / 82739 / BB | |
| EP1541574A4 (en) | Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient | |
| ECSP055768A (en) | CONDENSED AZOL-PYRIMIDINE DERIVATIVES | |
| TNSN07098A1 (en) | 2,6- substituted -4- monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists | |
| WO2005021515A3 (en) | Inhibitors of phosphodiesterase type-iv | |
| NO20075696L (en) | Nanoparticulated controlled release preparations comprising cyclosporin | |
| WO2007114848A3 (en) | Chemical compounds | |
| TNSN08131A1 (en) | Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist | |
| PL372466A1 (en) | Carboxylic acid compounds and drugs containing the compounds as the active ingredient | |
| AR062051A1 (en) | 2-PHENYLINDOLS AS ANTAGONISTS OF PROSTAGLANDINA D₂ RECEPTOR | |
| AR060403A1 (en) | AMINO COMPOUNDS- PYRIMIDINE 2.6- SUBSTITUTES -4- MONOSUSTITUTES AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEIVER | |
| WO2006085212A3 (en) | Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv | |
| ECSP993095A (en) | 1-ARYL-3- ARYL METHYL -8 -NAFTIRIDIN -4 (1H) - (ONAS) | |
| EP1666473A4 (en) | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | |
| ECSP982468A (en) | NICOTINAMIDE DERIVATIVES | |
| WO2017126700A9 (en) | Inhibitor of activity of vesicular nucleotide transporter | |
| JP2006502171A5 (en) | ||
| WO2002048397A3 (en) | Regulation of human adenylate cyclase, type vii | |
| BRPI0606843A2 (en) | nk 1 antagonists | |
| Bermudez et al. | Liposome-ciprofloxacin inhibits Mycobacterium avium subs hominissuis (MAH) microaggregate formation in a dose and time dependent manner | |
| DOP2003000724A (en) | CONDENSED AZOL-PYRIMIDINE DERIVATIVES | |
| TH43442A (en) | Nicotine amide derivatives | |
| WO2007046022A3 (en) | Inhibitors of phosphodiesterase type-iv |